[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@NEJM Avatar @NEJM NEJM

NEJM posts on X about c3, events, history, what is the most. They currently have XXXXXXX followers and XX posts still getting attention that total XXXXXX engagements in the last XX hours.

Engagements: XXXXXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXXXX #

Followers Line Chart

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence finance XXXX% countries XXXX%

Social topic influence c3 #21, events #790, history #4103, what is 2.38%, red 2.38%, education 2.38%, express 2.38%, 6 months 2.38%, to the 2.38%, level XXXX%

Top accounts mentioned or mentioned by @ashhematology @erictopol @doc_blocke @vfd_org @svinsociety @nishantuppal7 @drrishabhonco @patientstormdoc @bllphd @chrystalos @dglaucomflecken @nejmevidence @srm128 @asnkidney @nufeinbergmed @uabnews @cidrap @catharinazkh @umasschan @uwmedicine

Top Social Posts

Top posts by engagements in the last XX hours

"A 66-year-old man with COPD presented with a 2-week history of shortness of breath and cough and X days of left flank pain. Two days before presentation he had noted the appearance and rapid expansion of a mass on his left side. CT of the chest is shown. What is the underlying etiology"
X Link 2025-11-30T16:53Z 932.7K followers, 62.6K engagements

"In a phase X trial single-dose CRISPR-Cas9 gene editing targeting ANGPTL3 led to reductions in ANGPTL3 protein levels with few adverse events. Full trial results:"
X Link 2025-12-02T14:00Z 932.7K followers, 28.3K engagements

"For a preclinical grading system in a medical school should you support the continuation of the five-tier grading system (A B C D F) or recommend implementation of a pass/fail system Read the case vignette treatment options and vote:"
X Link 2025-12-05T14:00Z 932.7K followers, 8490 engagements

"In X of XX patients receiving immune checkpoint inhibitors cell-free DNA methylation profiling revealed multiorgan damage with immune-related adverse events often before symptoms appeared. Learn more:"
X Link 2025-12-10T22:30Z 933K followers, 35.3K engagements

"A 26-year-old woman was referred to the pulmonary hypertension clinic with a 6-month history of exertional dyspnea and hoarseness. Vocal-fold paralysis was seen on laryngoscopy (shown in a video). Read the full case details:"
X Link 2025-11-25T20:00Z 932.9K followers, 636.8K engagements

"Original Article: Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction (TARGET-FIRST trial) Editorial: Discontinuation of Aspirin in Acute Coronary Syndromes Treated with Coronary-Artery Stents #Cardiology"
X Link 2025-11-29T14:00Z 932.8K followers, 35.9K engagements

"Presented at #KidneyWk: In the PISCES trial involving participants receiving hemodialysis fish oil (n3 fatty acids) was compared with corn-oil placebo. The rate of serious cardiovascular events was lower with daily fish-oil supplementation. Full trial results: Editorial: Fish Oil for Patients Receiving Hemodialysis Red Herring or Great Catch @ASNKidney"
X Link 2025-11-07T16:35Z 933K followers, 192.3K engagements

"Bedside clinical skills have been diminished by an overreliance on technology. A new Review Article presents educational strategies for reinvigorating the bedside encounter and shows how much can be learned from it. Read the review Strategies to Reinvigorate the Bedside Clinical Encounter the latest in the Medical Education series by Brian T. Garibaldi MD MEHP and Stephen W. Russell MD from @NUFeinbergMed and the University of Alabama at Birmingham (@UABNews):"
X Link 2025-11-15T22:00Z 933K followers, 93.4K engagements

"New in the November XX 2025 issue of NEJM: Early Discontinuation of Aspirin after PCI (TARGET-FIRST trial) Early Withdrawal of Aspirin after PCI (NEO-MINDSET trial) Daily Mosnodenvir as Dengue Prophylaxis CRISPR-Cas9 Targeting ANGPTL3 Engasertib in Hereditary Hemorrhagic Telangiectasia Subscribe to NEJM for the latest medical research:"
X Link 2025-11-27T14:00Z 933K followers, 17.9K engagements

"Original Article: Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes (NEO-MINDSET trial) Editorial: Discontinuation of Aspirin in Acute Coronary Syndromes Treated with Coronary-Artery Stents #Cardiology"
X Link 2025-11-30T14:00Z 933K followers, 45.5K engagements

"Twelve former commissioners of the FDA express concern that the agencys recent moves will undermine a regulatory model designed to ensure vaccine safety effectiveness and availability. Read the full Perspective:"
X Link 2025-12-03T22:10Z 933K followers, 32.7K engagements

"A trial of pegcetacoplan a C3 and C3b inhibitor in patients with C3 glomerulopathy or primary immune-complex membranoproliferative glomerulonephritis showed that the drug significantly reduced proteinuria. Full VALIANT phase X trial results: Editorial: Pegcetacoplan for Treatment of C3 Glomerulopathy and Immune-Complex MPGN"
X Link 2025-12-03T22:30Z 933K followers, 13.6K engagements

"New in the December X 2025 issue of NEJM: Glucocorticoids for Community-Acquired Pneumonia (SONIA trial) Shunting for Idiopathic Normal-Pressure Hydrocephalus (PENS trial) Pegcetacoplan in C3 Glomerulopathy and IC-MPGN (VALIANT phase X trial) Subscribe to NEJM for the latest medical research:"
X Link 2025-12-04T14:00Z 933K followers, 35.4K engagements

"Immunizations against Covid-19 RSV and influenza have shown consistent effectiveness and safety and are associated with a substantially reduced risk of hospitalization and severe disease across populations. Findings from a @CIDRAP systematic review underscore the enduring value of immunization against respiratory viruses as a cornerstone of preventive care and support the feasibility of maintaining rigorous evidence-based guidance during periods of institutional disruption. Read the full article:"
X Link 2025-12-04T19:00Z 933K followers, 16.5K engagements

"Presented at #ASH25: In drug-resistant extramedullary myeloma dual treatment with talquetamab and teclistamab produced a response in XX% of patients and 12-month overall survival was 74%; however grade X or X adverse events were common. Full RedirecTT-1 phase 1b2 study results: @ASH_hematology"
X Link 2025-12-07T21:35Z 933K followers, 24.5K engagements

"Original Article: Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN (VALIANT phase X trial) Editorial: Pegcetacoplan for Treatment of C3 Glomerulopathy and Immune-Complex MPGN #Nephrology"
X Link 2025-12-08T19:00Z 933K followers, 10.8K engagements

"Presented at #ASH25: In the VAYHIT2 phase X trial ianalumab plus eltrombopag led to a longer time to treatment failure than placebo plus eltrombopag with a stable platelet response at X months in a higher percentage of patients with X mg/kg of ianalumab than with placebo. Full trial results: @ASH_hematology"
X Link 2025-12-09T12:35Z 933K followers, 13K engagements

"Which one of the following choices is the enzyme that is deficient in patients with Pompe disease"
X Link 2025-12-09T20:16Z 933K followers, 8367 engagements

"A new trial of pegcetacoplan a C3 and C3b inhibitor in patients with C3 glomerulopathy or primary immune-complex membranoproliferative glomerulonephritis showed that the drug significantly reduced proteinuria. Full VALIANT phase X trial results and Research Summary:"
X Link 2025-12-10T14:00Z 933K followers, 8672 engagements

"An 80-year-old man presented to the emergency department with a 12-hour history of pleuritic chest pain and an elevated d-dimer level. A CT scan showed an ulcerlike projection in the ascending thoracic aorta. Read the full case details in the Images in Clinical Medicine article Aortic Intramural Hematoma from Catharina Hospital (@CatharinaZKH):"
X Link 2025-12-10T23:00Z 933K followers, 10.7K engagements

"Presented at #SVIN25: CREST-2: In high-grade asymptomatic carotid stenosis addition of stenting to medical therapy led to a lower risk of stroke over a 4-year period. Endarterectomy did not lead to a significant benefit. Full results: Editorial: Managing Asymptomatic Carotid Stenosis @svinsociety"
X Link 2025-11-21T15:35Z 933K followers, 382.7K engagements

"In a new trial one dose of an HPV vaccine was noninferior to two doses in preventing HPV type XX or XX infection. Full ESCUDDO trial results: Editorial: Evidence to Action Single-Dose HPV Vaccination and Cervical HPV Infection"
X Link 2025-12-03T22:15Z 933K followers, 15.8K engagements

"Idiopathic normal-pressure hydrocephalus (iNPH) typically causes gait cognitive and urinary impairment. The diagnosis is aided by a medical evaluation imaging findings and tests that predict improvement with CSF shunting. Learn more in the Review Article Idiopathic Normal-Pressure Hydrocephalus by Mark D. Johnson MD PhD and Michael A. Williams MD from @UMassChan and @UWMedicine:"
X Link 2025-12-03T22:40Z 933K followers, 47.6K engagements

"Treatments are needed for C3 glomerulopathy and primary immune-complex membranoproliferative glomerulonephritis. Pegcetacoplan a targeted C3 and C3b inhibitor showed promise in phase X trials. Research findings from the VALIANT phase X trial are summarized in a new Quick Take video"
X Link 2025-12-07T20:00Z 933K followers, 14.5K engagements

"Presented at #ASH25: In relapsed or refractory T-cell acute lymphoblastic leukemia off-the-shelf allogeneic base-edited CAR7 T cells mediated responses in XX patients enabling stem-cell transplantation in X patients in deep remission. Full study results: @ASH_hematology"
X Link 2025-12-08T21:35Z 933K followers, 38.3K engagements

"Perspective by Stacie B. Dusetzina PhD and Rachel E. Sachs JD MPH: Insurance Coverage and Pricing of Weight-Loss Drugs in the United States #HealthPolicy #PublicHealth"
X Link 2025-12-11T22:00Z 933K followers, 2709 engagements